BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9087492)

  • 1. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
    Ponte C; Parra A; Nieto E; Soriano F
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2698-702. PubMed ID: 9124825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment.
    Candiani G; Abbondi M; Borgonovi M; Williams R
    J Antimicrob Chemother; 1997 Feb; 39(2):199-207. PubMed ID: 9069540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology analysis of 51 penicillin-intermediate
    Zhang J; Hu DK; Gao CY; Shen WW; Luo XH; Yu J; Li XY; Jiang XY; Zhu WS; Chen WQ
    J Int Med Res; 2020 Jun; 48(6):300060520919061. PubMed ID: 32529912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.
    Croisier-Bertin D; Piroth L; Charles PE; Larribeau A; Biek D; Ge Y; Chavanet P
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3557-63. PubMed ID: 21576444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
    Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
    J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
    Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
    Fukuoka T; Kawada H; Kitayama A; Koga T; Kubota M; Harasaki T; Kamai Y; Ohya S; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):23-7. PubMed ID: 9449255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
    Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of tedizolid phosphate (TR-701) in murine models of infection with penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.
    Choi S; Im W; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4713-7. PubMed ID: 22713339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.